143 related articles for article (PubMed ID: 22019956)
21. Urine detection of survivin and diagnosis of bladder cancer.
Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
[TBL] [Abstract][Full Text] [Related]
22. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells.
Yang D; Song X; Zhang J; Ye L; Wang S; Che X; Wang J; Zhang Z; Wang L; Shi W
Acta Biochim Biophys Sin (Shanghai); 2010 Feb; 42(2):137-44. PubMed ID: 20119625
[TBL] [Abstract][Full Text] [Related]
25. Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer.
Xi RC; Sheng YR; Chen WH; Sheng L; Gang JJ; Tong Z; Shan Z; Ying GH; Dong LC
J Surg Oncol; 2013 Apr; 107(5):550-4. PubMed ID: 23090902
[TBL] [Abstract][Full Text] [Related]
26. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
[TBL] [Abstract][Full Text] [Related]
27. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study on bladder cancer by the small interfering RNA targeting survivin].
Hou JQ; He J; Wen DG; Wang XL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):401-4. PubMed ID: 17680529
[TBL] [Abstract][Full Text] [Related]
29. Spectroscopic features of dual fluorescence/luminescence resonance energy-transfer molecular beacons.
Tsourkas A; Behlke MA; Xu Y; Bao G
Anal Chem; 2003 Aug; 75(15):3697-703. PubMed ID: 14572032
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser.
Karpova TS; Baumann CT; He L; Wu X; Grammer A; Lipsky P; Hager GL; McNally JG
J Microsc; 2003 Jan; 209(Pt 1):56-70. PubMed ID: 12535185
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
32. Value of urinary survivin as a diagnostic marker in bladder cancer.
Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
[TBL] [Abstract][Full Text] [Related]
33. A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP-->YFP fluorescence resonance energy transfer (FRET).
He L; Olson DP; Wu X; Karpova TS; McNally JG; Lipsky PE
Cytometry A; 2003 Oct; 55(2):71-85. PubMed ID: 14505312
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence resonance energy transfer of GFP and YFP by spectral imaging and quantitative acceptor photobleaching.
Dinant C; van Royen ME; Vermeulen W; Houtsmuller AB
J Microsc; 2008 Jul; 231(Pt 1):97-104. PubMed ID: 18638193
[TBL] [Abstract][Full Text] [Related]
35. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
36. FRET based ratio-metric sensing of hyaluronidase in synthetic urine as a biomarker for bladder and prostate cancer.
Chib R; Raut S; Fudala R; Chang A; Mummert M; Rich R; Gryczynski Z; Gryczynski I
Curr Pharm Biotechnol; 2013; 14(4):470-4. PubMed ID: 23360262
[TBL] [Abstract][Full Text] [Related]
37. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
[TBL] [Abstract][Full Text] [Related]
39. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
[TBL] [Abstract][Full Text] [Related]
40. Survivin: role in diagnosis, prognosis, and treatment of bladder cancer.
Akhtar M; Gallagher L; Rohan S
Adv Anat Pathol; 2006 May; 13(3):122-6. PubMed ID: 16778475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
